Evidence map›Paper›PMID 34203979›Full record

ArticleCancers2021

Serum Exosomal microRNA-21, 222 and 124-3p as Noninvasive Predictive Biomarkers in Newly Diagnosed High-Grade Gliomas: A Prospective Study.

Debora Olioso, Mario Caccese, Alessandra Santangelo, Giuseppe Lippi, Vittorina Zagonel, Giulio Cabrini, Giuseppe Lombardi, Maria Cristina Dechecchi

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 3 pooled it
3.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 3 syntheses or guidelines pooled it, 53 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Current Understanding of the Exosomes and Their Associated Biomolecules in the Glioblastoma Biology, Clinical Treatment, and Diagnosis.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2025
    Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Debora OliosoDepartment of Neurosciences, Biomedicine and Movement, University of Verona, 37126 Verona, Italy.ORCID 0000-0002-9048-0364
Mario CacceseDepartment of Oncology Oncology 1, Veneto Institute of Oncology IOV-IRCSS, 35128 Padova, Italy.
Alessandra SantangeloDepartment of Neurosciences, Biomedicine and Movement, University of Verona, 37126 Verona, Italy.
Giuseppe LippiDepartment of Neurosciences, Biomedicine and Movement, University of Verona, 37126 Verona, Italy.ORCID 0000-0001-9523-9054
Vittorina ZagonelDepartment of Oncology Oncology 1, Veneto Institute of Oncology IOV-IRCSS, 35128 Padova, Italy.
Giulio CabriniDepartment of Neurosciences, Biomedicine and Movement, University of Verona, 37126 Verona, Italy.
Giuseppe LombardiDepartment of Oncology Oncology 1, Veneto Institute of Oncology IOV-IRCSS, 35128 Padova, Italy.ORCID 0000-0003-1316-2132
Maria Cristina DechecchiDepartment of Neurosciences, Biomedicine and Movement, University of Verona, 37126 Verona, Italy.ORCID 0000-0001-7357-2104
University of Verona · ITIstituto Oncologico Veneto · IT

Funding

Ricerca Corrente IOV-IRCCS 2018 and 2021 and FRI Fondo Ricerca Indipendente AOUI Verona Ricerca Corrente IOV-IRCCS 2018 and 2021
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

circulating miRNAsexosomeshigh-grade gliomaliquid biopsy

Identifiers

PMID34203979
PMCPMC8232769
OpenAlexW3171771536

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.